AMERISAFE, Inc. $AMSF Shares Sold by ProShare Advisors LLC

ProShare Advisors LLC reduced its stake in AMERISAFE, Inc. by 5.7% in Q2, selling 8,292 shares. AMERISAFE's stock opened at $41.39, with a 12-month range of $39.09 to $59.51. Analysts predict a 2.45 EPS for the fiscal year. The company announced a $1.00 special dividend, with a yield of 394.0%. The stock has a consensus rating of "Moderate Buy" with a target price of $55.00.

ProShare Advisors LLC reduced its stake in shares of AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) by 5.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 138,042 shares of the insurance provider's stock after selling 8,292 shares during the quarter. ProShare Advisors LLC owned 0.73% of AMERISAFE worth $6,037,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Russell Investments Group Ltd. increased its holdings in shares of AMERISAFE by 45.5% during the 1st quarter. Russell Investments Group Ltd. now owns 69,169 shares of the insurance provider's stock valued at $3,635,000 after purchasing an additional 21,628 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in AMERISAFE by 9.3% during the first quarter. Charles Schwab Investment Management Inc. now owns 723,562 shares of the insurance provider's stock worth $38,023,000 after buying an additional 61,767 shares in the last quarter. Principal Financial Group Inc. grew its position in AMERISAFE by 2.5% during the first quarter. Principal Financial Group Inc. now owns 94,924 shares of the insurance provider's stock valued at $4,988,000 after buying an additional 2,288 shares during the period. Mirae Asset Global Investments Co. Ltd. grew its position in AMERISAFE by 11.6% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 17,324 shares of the insurance provider's stock valued at $758,000 after buying an additional 1,800 shares during the period. Finally, Strs Ohio purchased a new position in AMERISAFE in the first quarter valued at $646,000. Hedge funds and other institutional investors own 97.41% of the company's stock.

AMERISAFE Trading Up 0.5%

Shares of AMERISAFE stock opened at $41.39 on Friday. AMERISAFE, Inc. has a twelve month low of $39.09 and a twelve month high of $59.51. The firm has a market capitalization of $783.26 million, a PE ratio of 15.86 and a beta of 0.33. The firm's 50-day moving average price is $42.32 and its 200 day moving average price is $44.42.

AMERISAFE (NASDAQ:AMSF - Get Free Report) last announced its earnings results on Wednesday, October 29th. The insurance provider reported $0.55 EPS for the quarter, meeting analysts' consensus estimates of $0.55. The business had revenue of $71.29 million during the quarter, compared to analysts' expectations of $78.29 million. AMERISAFE had a return on equity of 17.16% and a net margin of 16.12%. On average, sell-side analysts predict that AMERISAFE, Inc. will post 2.45 EPS for the current fiscal year.

AMERISAFE Dividend Announcement

The company also recently disclosed a special dividend, which will be paid on Friday, December 12th. Investors of record on Friday, December 5th will be paid a $1.00 dividend. This represents a yield of 394.0%. The ex-dividend date of this dividend is Friday, December 5th. AMERISAFE's dividend payout ratio is currently 59.77%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on AMSF. Citigroup reissued a "market outperform" rating on shares of AMERISAFE in a research note on Thursday, October 30th. JMP Securities reduced their price target on AMERISAFE from $65.00 to $60.00 and set a "market outperform" rating for the company in a report on Tuesday, October 14th. Truist Financial lowered their price target on AMERISAFE from $54.00 to $50.00 and set a "hold" rating on the stock in a research report on Monday, July 28th. Wall Street Zen lowered AMERISAFE from a "hold" rating to a "sell" rating in a report on Saturday, November 8th. Finally, Weiss Ratings restated a "hold (c)" rating on shares of AMERISAFE in a research report on Wednesday, October 8th. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $55.00.

Get Our Latest Research Report on AMERISAFE

AMERISAFE Company Profile

(Free Report)

AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.

Should You Invest $1,000 in AMERISAFE Right Now?

Before you consider AMERISAFE, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.

While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here